Abstract:Objective: Although multiple sclerosis (MS) is known to be an immune-mediated disease, very little is known about its etiopathogenesis. MicroRNAs (miRNAs) are small non-coding proteins involved in the regulation of gene expression. T-cell activation potential in neurodegenerative diseases has been a research topic of interest in recent years Cytokines play an important role in the course and pathogenesis of MS, The aim of the present study was to analyze expression levels of miR-20, miR-21, miR-26, miR-155, and Let-7, which target the cytokines interleukin IL-17 and IL-23, in order to evaluate the relationship between MS and miRNAs that modulate the expression of cytokines involved in the autoimmune pathway. Methods:The study included 20 relapsing-remitting multiple sclerosis (MS) patients who were at least 18 years of age and were undergoing outpatient immunomodulatory therapy and 20 healthy, unrelated individuals who had no systemic disease and were not taking any medication as a control group. Peripheral blood samples were collected from all participants into EDTA-containing tubes and plasma was isolated for cDNA synthesis . From these cDNA samples, miRNA expression levels were quantitatively analyzed via melting curve analysis using the miScript SYBR Green kit in real-time PCR device. Results: Comparison of miRNA expression levels in the peripheral blood samples and MS patients and healthy subjects revealed that the MS patients had significant upregulation of miR-20 and downregulation of miR-26 and miR-155 compared to the control group (p<0.005). Conclusions:Dysregulation of miRNA expression may play a role in the pathogenesis of MS.

MicroRNAs associated with the pathogenesis of multiple sclerosis

MicroRNA in Multiple Sclerosis

miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.

MicroRNAs As T Lymphocyte Regulators in Multiple Sclerosis

MicroRNA Expression Aberration in Chinese Patients with Relapsing Remitting Multiple Sclerosis.

Mirnas Participate in MS Pathological Processes and Its Therapeutic Response

Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation

MicroRNAs and their Implications in CD4+ T-cells, Oligodendrocytes and Dendritic Cells in Multiple Sclerosis Pathogenesis

The role of microRNAs involved in the disorder of blood–brain barrier in the pathogenesis of multiple sclerosis

Roles of miRNA, lcnRNA, and circRNA and Their Implications in Cellular Pathways

Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis

MiRNA-based therapeutic potential in multiple sclerosis

Recent Advances of Long Noncoding RNAs Involved in the Development of Multiple Sclerosis.

Identification of the circRNA/miRNA/mRNA network and hub mRNAs involved in multiple sclerosis through bioinformatics analysis

Cognitive frailty predicting death and disability in Chinese elderly

Advances in research of the role of microglia polarization in the mechanisms of pathogenesis of multiple sclerosis

Environmental Influencers, MicroRNA, and Multiple Sclerosis

MicroRNAs in microglia: deciphering their role in neurodegenerative diseases

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis

Inverse Correlation of Expression of Microrna‐140‐5p with Progression of Multiple Sclerosis and Differentiation of Encephalitogenic T Helper Type 1 Cells

MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases